One of Montana’s largest health clinics that serves people in poverty has cut back services and laid off workers.
Almost 40 years after an adcomm’s warning: FDA and sponsors withdraw approval for anabolic steroid
The FDA announced that it’s withdrawing the approval of Gemini Laboratories’ anabolic steroid Oxandrin (oxandrolone) and four generic versions, a decades-old treatment once indicated for